Newsletter Signup | Join Community
25
1
Stay Current With Gastrointestinal Stromal Tumors Treatment Advances & Connect with Others
1 in 4 Gleevec treated GIST patients has survived 10 years.
New Drug Shows Improved Outcomes for Patients with Advanced Metastatic Mid-gut Neuroendocrine Tumors
Surgery in Responding Patients Feasible for GIST
Increased Doses of Gleevec® for Gleevec-Resistant Gastrointestinal Stromal Tumors (GIST) Effective
Surgery for Residual GIST May Improve Outcomes
Increased Doses of Gleevec® More Effective in Gastrointestinal Stromal Tumors
Can anyone recommend where to be treated with GIST; i dont think the local oncologist sees to many…
